Elevar Therapeutics
Seong Jang currently serves as the Chief Operating Officer at Elevar Therapeutics since March 2022. Prior to this role, Seong Jang worked at the FDA from September 2002 to February 2022, holding the position of Lead Pharmacologist in the Division of Infectious Disease Pharmacology within the Office of Clinical Pharmacology. Additionally, Seong Jang was a Reviewer in the Division of Clinical Pharmacology 4, also under the Office of Clinical Pharmacology at the FDA.
This person is not in any offices